Skip to content
TrialScanner

NCT02705755

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Phase 2CompletedTBPHLead

Registry record

Lead sponsor
Theravance Biopharma
Conditions
Neurogenic Orthostatic Hypotension; Multiple System Atrophy (MSA) With Orthostatic Hypotension; Pure Autonomic Failure; Parkinson Disease; Hypotension, Orthostatic
Primary completion
Jul 24, 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02705755 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02705755: TD-9855 Phase 2 in Neurogenic... | TrialScanner